Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Bronchopulmonary Dysplasia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cliniques Universitaires Saint-Luc (UCLouvain), Brussels, Belgium
Contact: Study coordinator (Olivier Danhaive, M.D.) · olivier.danhaive@saintluc.uclouvain.be · +32 2 764 79 00Contact: Principal Investigator (Olivier Danhaive, M.D.)ISPPC CHU Charleroi, Charleroi, Belgium
Contact: Study coordinator (Serge Vanden Eijnden, M.D.) · serge.vandeneijnden@chu-charleroi.be · +32 7 192 12 43Contact: Principal Investigator (Serge Vanden Eijnden, M.D.)Clinique CHC Montlégia, Liège, Belgium
Contact: Principal Investigator (Pierre Maton, M.D.)AOU Careggi, Florence, Italy
IRCCS Instituto Giannina Gaslini, Genova, Italy
Contact: Principal Investigator (Giorgia Brigati, M.D.)Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
AOU Policlinico di Modena, Modena, Italy
Contact: Principal Investigator (Alberto Berardi, M.D.)Unità di Fase I della UOC Terapia Intensiva e Patologia Neonatale, Assistenza Neonatale (TINI) dell'Azienda Ospedale Università di Padova, Padua, Italy
Contact: Principal Investigator (Eugenio Baraldi, Prof)
Study leads
Beatrice De Vos, M.D., Ph.D.
Study Chair
EXO Biologics SA